证券代码：300955 证券简称：嘉亨家化 嘉亨家化股份有限公司 投资者关系活动记录表 编号：2023-006  特定对象调研  分析师会议  媒体采访  业绩说明会 投资者关系活动  新闻发布会  路演活动  现场参观 类别  其他 深圳证券交易所“踔厉奋发新征程 投教服务再出 发”走进上市公司—嘉亨家化主题投教活动 深圳证券交易所投资者服务部、福建证监局、福建省证券 参与单位名称及 期货业协会、福建省上市公司协会、福建经济广播电台、华福 人员姓名 证券以及投资者 时间 2023 年 11月 29 日(周三)下午 地点 公司会议室 上市公司接待人 公司董事、副总经理、董事会秘书徐勇先生，证券事务代 员姓名 表傅冰红女士 一、参观公司展厅及部分生产车间 二、董事会秘书徐勇先生对公司及所属行业的基本情况 进行介绍 三、投资者互动交流： ...

Financial Performance - In the first three quarters of 2023, the company achieved a revenue of 729 million CNY, a decrease of 45.84% year-on-year, equating to a drop of 26.19 million CNY [1] - The net profit margin for the same period was 4.51% [1] - The decline in revenue and net profit is attributed to lower-than-expected industry demand and a reduction in customer orders [1] Operational Insights - The new factory in Huzhou is in the initial production phase, which has led to increased management, R&D, and financial expenses, totaling an increase of 2.37 million CNY [1] - The overall gross profit margin remains low due to high fixed costs associated with depreciation and amortization [1] - The company is actively expanding its customer base and new business opportunities [1] R&D and Market Strategy - The company has increased its investment in R&D, focusing on formula development, packaging innovation, and efficacy testing [2] - Collaboration with large clients is progressing well, with several clients having completed factory inspections and product trials [2] - The company aims to enhance its ODM service capabilities and expand its market presence [3] Customer and Product Structure - The primary customers are well-known domestic and international brands, with a stable customer base [3] - The product offerings mainly include skincare and hair care products [3] Future Outlook - The management expresses confidence in improving profitability as production capacity utilization increases and R&D capabilities enhance [2] - The company anticipates growth in the cosmetics industry, driven by a large population base and low per capita consumption [2]

[Main Financial Data](index=1&type=section&id=Main%20Financial%20Data) This section provides an overview of the company's key financial performance, including accounting data, financial indicators, non-recurring items, and detailed analysis of changes in balance sheet, income statement, and cash flow items [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q3 2023 and YTD, the company experienced significant declines in revenue and net profit, primarily due to decreased revenue, low capacity utilization at Huzhou Jiaheng, and increased management and R&D expenses Key Financial Indicators for Q3 2023 and YTD | Indicator | Current Period (Q3) | YTD | YTD vs. Prior Year Change | | :--- | :--- | :--- | :--- | | Operating Revenue | 284 million RMB | 729 million RMB | -4.51% | | Net Profit Attributable to Shareholders of Listed Company | 12.5184 million RMB | 26.1927 million RMB | -45.84% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-Recurring Items) | 12.3756 million RMB | 25.9543 million RMB | -44.33% | | Net Cash Flow from Operating Activities | - | 99.5237 million RMB | 102.24% | | Basic Earnings Per Share (RMB/share) | 0.12 | 0.26 | -45.83% | | Weighted Average Return on Net Assets | 1.29% | 2.65% | -2.34% | | Total Assets (End of Reporting Period) | 1.699 billion RMB | - | 9.75% (vs. end of prior year) | [4](index=4&type=chunk)[5](index=5&type=chunk) - Net profit significantly declined due to slightly lower revenue, low capacity utilization at subsidiary Huzhou Jiaheng which is in its initial production phase, and a combined **17.9551 million RMB** increase in management and R&D expenses[13](index=13&type=chunk) - The company changed accounting policies and retrospectively adjusted financial data due to the Ministry of Finance's Interpretation No. 16 of Accounting Standards[4](index=4&type=chunk)[5](index=5&type=chunk) [Non-Recurring Gains and Losses](index=2&type=section&id=Non-Recurring%20Gains%20and%20Losses) YTD non-recurring gains and losses totaled 0.2384 million RMB, primarily from government grants offset by other non-operating income and asset disposal losses Non-Recurring Gains and Losses YTD | Item | YTD Amount (RMB) | | :--- | :--- | | Non-current asset disposal gains/losses | -9,701.32 | | Government grants included in current profit/loss | 1,895,027.07 | | Other non-operating income and expenses | -171,552.06 | | Less: Income tax impact | 1,475,331.04 | | **Total** | **238,442.65** | [7](index=7&type=chunk) [Analysis of Major Financial Indicator Changes](index=3&type=section&id=Analysis%20of%20Major%20Financial%20Indicator%20Changes) The company experienced significant changes in financial indicators, with long-term borrowings and deferred tax assets increasing, while R&D and financial expenses rose, impacting net profit, and cash flows showing varied trends [Balance Sheet Item Changes](index=3&type=section&id=Balance%20Sheet%20Item%20Changes) Significant balance sheet changes include a 167.96% increase in long-term borrowings due to Huzhou Jiaheng's bank loans and a 61.60% rise in deferred tax assets from its deductible losses - Long-term borrowings increased by **167.96%** from the beginning of the year, primarily due to increased long-term bank loans for subsidiary Huzhou Jiaheng[11](index=11&type=chunk) - Deferred tax assets increased by **61.60%** from the beginning of the year, mainly due to increased deductible temporary differences from subsidiary Huzhou Jiaheng's deductible losses[11](index=11&type=chunk) - Other current assets decreased by **93.50%** from the beginning of the year, primarily due to subsidiary Huzhou Jiaheng receiving incremental VAT refund and a reduction in ending VAT credit[11](index=11&type=chunk) [Income Statement Item Changes](index=3&type=section&id=Income%20Statement%20Item%20Changes) Income statement items saw substantial changes, with financial expenses surging nearly 40 times, R&D expenses increasing by 57.08%, and credit impairment losses expanding by 267.45%, all contributing to net profit decline - Financial expenses increased by **3996.20%** year-over-year, mainly due to increased interest expenses from bank borrowings and reduced exchange gains from currency fluctuations[12](index=12&type=chunk) - R&D expenses increased by **57.08%** year-over-year, primarily due to increased R&D investment by subsidiary Huzhou Jiaheng[12](index=12&type=chunk) - Credit impairment losses increased by **267.45%** year-over-year, mainly due to increased provision for doubtful accounts on accounts receivable during the period[12](index=12&type=chunk) - Income tax expense decreased by **134.04%** year-over-year, primarily due to increased deductible temporary differences from subsidiary Huzhou Jiaheng's deductible losses and deferred income, and reduced operating profit of subsidiary Zhejiang Jiaheng[13](index=13&type=chunk) [Cash Flow Statement Item Changes](index=4&type=section&id=Cash%20Flow%20Statement%20Item%20Changes) Cash flow structure changed significantly, with operating cash flow increasing by 102.24%, investment cash outflow expanding by 77.64%, and financing cash flow surging by 928.40% - Net cash flow from operating activities increased by **102.24%** year-over-year, primarily due to reduced payments for goods and services and receipt of incremental VAT refunds[14](index=14&type=chunk) - Net cash outflow from investing activities increased by **77.64%** year-over-year, mainly due to increased investment in subsidiary Huzhou Jiaheng's cosmetics and home care product manufacturing base project[14](index=14&type=chunk) - Net cash flow from financing activities increased by **928.40%** year-over-year, primarily due to increased bank borrowings during the period[14](index=14&type=chunk) [Shareholder Information](index=4&type=section&id=Shareholder%20Information) This section details the company's shareholder structure, including the total number of common shareholders and the holdings of the top shareholders [Common Shareholder Holdings](index=4&type=section&id=Common%20Shareholder%20Holdings) As of the reporting period end, the company had 7,643 common shareholders, with controlling shareholder Zeng Bensheng holding 55.49%, indicating highly concentrated equity, and several top ten investment partnerships controlled by the same individual - As of the end of the reporting period, the company had **7,643** common shareholders[16](index=16&type=chunk) Top Five Shareholder Holdings | Shareholder Name | Shareholder Nature | Shareholding Ratio | Number of Shares | | :--- | :--- | :--- | :--- | | Zeng Bensheng | Foreign natural person | 55.49% | 55,938,212 | | Shanghai Huiying Investment Partnership (Limited Partnership) | Domestic non-state legal person | 4.48% | 4,515,619 | | Fujian Huixin Zhicheng Equity Investment Partnership (Limited Partnership) | Domestic non-state legal person | 2.09% | 2,108,635 | | Quanzhou Zhonghe Equity Investment Partnership (Limited Partnership) | Domestic non-state legal person | 1.87% | 1,881,509 | | Fujian Huishui Zhicheng Equity Investment Partnership (Limited Partnership) | Domestic non-state legal person | 1.76% | 1,776,101 | [16](index=16&type=chunk) - Shareholders Fujian Huixin Zhicheng, Fujian Huishui Zhicheng, and Fujian Huohuo Zhicheng Equity Investment Partnerships (Limited Partnership) are all controlled by Zheng Ping[17](index=17&type=chunk) [Other Significant Matters](index=6&type=section&id=Other%20Significant%20Matters) This section confirms that there were no other significant matters requiring disclosure during the reporting period [Other Significant Matters](index=6&type=section&id=Other%20Significant%20Matters) No other significant matters required disclosure during the reporting period - This section is marked as 'Not Applicable,' indicating no other significant matters during the reporting period[19](index=19&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Quarterly%20Financial%20Statements) This section presents the company's consolidated quarterly financial statements, including the balance sheet, income statement, cash flow statement, and details on the impact of accounting standard changes [Consolidated Balance Sheet](index=6&type=section&id=Consolidated%20Balance%20Sheet) As of September 30, 2023, total assets were 1.699 billion RMB, total liabilities 719 million RMB (up 28.62% due to long-term borrowings), and equity attributable to parent company 980 million RMB Consolidated Balance Sheet Key Items (Unit: RMB) | Item | September 30, 2023 | January 1, 2023 | | :--- | :--- | :--- | | Total Assets | 1,699,117,501.28 | 1,548,235,483.48 | | Total Liabilities | 718,759,840.41 | 558,823,707.54 | | Total Equity Attributable to Parent Company | 980,357,660.87 | 989,411,775.94 | [21](index=21&type=chunk)[22](index=22&type=chunk) [Consolidated Income Statement](index=8&type=section&id=Consolidated%20Income%20Statement) In Q1-Q3 2023, revenue was 729 million RMB (down 4.51%), total costs 705 million RMB, operating profit 24.1 million RMB (down 56.61%), and net profit attributable to parent 26.19 million RMB (down 45.84%) Consolidated Income Statement Key Items (YTD, Unit: RMB) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Total Operating Revenue | 728,517,781.25 | 762,954,252.52 | | Total Operating Costs | 704,508,293.67 | 709,499,338.40 | | Operating Profit | 24,101,225.25 | 55,541,790.50 | | Total Profit | 23,890,480.50 | 55,126,925.68 | | Net Profit | 26,192,717.31 | 48,364,089.57 | [23](index=23&type=chunk)[25](index=25&type=chunk) [Consolidated Cash Flow Statement](index=10&type=section&id=Consolidated%20Cash%20Flow%20Statement) In Q1-Q3 2023, cash and cash equivalents decreased by 18.95 million RMB; operating cash flow was 99.52 million RMB (up 102.24%), investing cash outflow 218 million RMB, and financing cash inflow 99.26 million RMB (up 928.40%) Consolidated Cash Flow Statement Key Items (YTD, Unit: RMB) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 99,523,705.31 | 49,209,755.29 | | Net Cash Flow from Investing Activities | -217,680,022.60 | -122,541,822.79 | | Net Cash Flow from Financing Activities | 99,256,318.46 | 9,651,495.69 | | Net Increase in Cash and Cash Equivalents | -18,954,344.71 | -61,612,938.24 | [26](index=26&type=chunk)[27](index=27&type=chunk) [Impact of Accounting Standard Changes](index=11&type=section&id=Impact%20of%20Accounting%20Standard%20Changes) Effective January 1, 2023, the company adopted Interpretation No. 16, adjusting deferred tax assets by 7.86 million RMB, deferred tax liabilities by 6.97 million RMB, and retained earnings by 0.887 million RMB - The company adopted 'Interpretation No. 16 of Enterprise Accounting Standards' from January 1, 2023, and adjusted relevant items in the financial statements at the beginning of the first year of implementation[28](index=28&type=chunk) Impact of Accounting Standard Changes on Consolidated Balance Sheet as of January 1, 2023 (Unit: RMB) | Item | Adjustment Amount | | :--- | :--- | | Deferred Tax Assets | +7,861,162.67 | | Deferred Tax Liabilities | +6,974,114.68 | | Retained Earnings | +887,047.99 | [29](index=29&type=chunk) [Audit Opinion](index=11&type=section&id=Audit%20Opinion) The company's Q3 2023 report is unaudited - The company's third-quarter report is unaudited[31](index=31&type=chunk)

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-040 嘉亨家化股份有限公司 嘉亨家化股份有限公司（以下简称"公司"）第二届董事会第十二次会议于 2023 年 10 月 24 日在公司会议室以现场与通讯相结合的方式召开，会议通知及 材料于 2023 年 10 月 20 日以电子邮件、电话及微信等方式送达全体董事、监事 及高级管理人员。本次会议由公司董事长曾本生先生主持，会议应到董事 7 名， 实到董事 7 名（其中董事曾焕彬先生，独立董事王清木先生以通讯方式出席）。 公司监事及高级管理人员列席了本次会议。本次会议的召集、召开符合《中华人 民共和国公司法》及其他法律法规和《公司章程》的相关规定。 二、董事会会议审议情况 审议通过了《关于公司 2023 年第三季度报告的议案》 经审议，董事会认为：《2023 年第三季度报告》编制程序符合法律、行政 法规及中国证监会的有关规定，报告内容真实、准确、完整地反映了公司经营、 管理及财务等各方面的实际情况，不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）披露的《2023 年第三季度报告》（公 ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-041 审议通过了《关于公司 2023 年第三季度报告的议案》 经审议，公司监事会认为：董事会编制和审核公司《2023 年第三季度报告》 的程序符合法律、行政法规及中国证监会的有关规定，报告内容真实、准确、完 整地反映了公司经营、管理及财务等各方面的实际情况，不存在任何虚假记载、 误导性陈述或重大遗漏。 具体内容详见公司同日于巨潮资讯网（www.cninfo.com.cn）披露的《2023 年第三季度报告》（公告编号：2023-039）。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 嘉亨家化股份有限公司 第二届监事会第十一次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 嘉亨家化股份有限公司（以下简称"公司"）第二届监事会第十一次会议于 2023 年 10 月 24 日在公司会议室以现场与通讯相结合的方式召开，会议通知及 材料于 2023 年 10 月 20 日以电子邮件、电话及微信等方式送达全体监事。本次 会议由公司监事会主席吴丽萍女士主持，会议应 ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-038 嘉亨家化股份有限公司 关于原合计持股 5%以上股东减持计划期限届满的公告 公司原合计持股 5%以上股东福建汇鑫至成股权投资合伙企业（有限合伙）、 福建汇水至成股权投资合伙企业（有限合伙）、福建汇火至成股权投资合伙企 业（有限合伙）保证向本公司提供的信息内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 嘉亨家化股份有限公司（以下简称"公司"或"嘉亨家化"）于 2023 年 2 月 9 日在巨潮资讯网上披露了《关于合计持股 5%以上股东减持计划的预披露公告》 （公告编号：2023-002），福建汇鑫至成股权投资合伙企业（有限合伙）（以下 简称"福建汇鑫"）、福建汇水至成股权投资合伙企业（有限合伙）（以下简称"福 建汇水"）、福建汇火至成股权投资合伙企业（有限合伙）（以下简称"福建汇火"） 计划通过大宗交易、集中竞价交易方式减持公司股份不超过 2,016,000 股，即减 持比例不超过公司总股本的 2%，以集中竞价方式减持的，自减持计划公告之日 起 15 个交易日 ...

嘉亨家化股份有限公司 证券代码：300955 证券简称：嘉亨家化 公告编号：2023-036 关于全资子公司《化妆品生产许可证》变更的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 嘉亨家化股份有限公司（以下简称"公司"）全资子公司湖州嘉亨实业有限公 司（以下简称"湖州嘉亨"）于近日取得浙江省药品监督管理局换发的《化妆品生 产许可证》，同意湖州嘉亨《化妆品生产许可证》的变更申请。变更后《化妆品 生产许可证》新增了生产许可项目，其他内容不变。变更后的《化妆品生产许可 证》具体内容如下： 一、《化妆品生产许可证》基本情况 企业名称：湖州嘉亨实业有限公司 统一社会信用代码：91330503MA2B3M2H9W 有效期至：2027 年 3 月 8 日 发证机关：浙江省药品监督管理局 发证日期：2023 年 9 月 25 日 二、对公司的影响 公司全资子公司湖州嘉亨本次《化妆品生产许可证》的变更涉及生产许可范 1 围的信息变更，增加了"气雾剂及有机溶剂单元#"的生产许可项目。此次变更为 湖州嘉亨产品进行商业化生产提供了资质保障；有利于发挥湖州嘉亨的产能优势， 更好 ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-037 嘉亨家化股份有限公司 关于全资子公司取得《农药生产许可证》的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 嘉亨家化股份有限公司（以下简称"公司"）全资子公司湖州嘉亨实业有限公 司（以下简称"湖州嘉亨"）于近日收到浙江省农业农村厅颁发的《农药生产许可 证》，现将相关信息公告如下： 一、《农药生产许可证》基本情况 编号：农药生许（浙）0089 生产企业名称：湖州嘉亨实业有限公司 生产范围：驱蚊液、驱蚊花露水 首次批准日期：2023 年 09 月 22 日 有效期至：2028 年 09 月 21 日 发证机关：浙江省农业农村厅 二、对公司的影响 湖州嘉亨此次取得《农药生产许可证》后即可依法开展相关业务活动，为湖 州嘉亨驱蚊花露水等相关产品进行商业化生产提供了资质保障；有利于公司实现 相关产品的产能扩大，保持稳定的生产能力和产品质量；有利于公司业务的稳健 增长和可持续发展以及公司战略布局实施。上述事项短期内不会对公司业绩产生 1 统一社会信用代码：91330503MA2B3M2H9W 法定 ...

嘉亨家化股份有限公司 简式权益变动报告书 上市公司信息 上市公司名称：嘉亨家化股份有限公司 股票上市地点：深圳证券交易所 股票简称：嘉亨家化 股票代码：300955 信息披露义务人信息 信息披露义务人 1 名称：福建汇鑫至成股权投资合伙企业（有限合伙） 注册地址：福建省泉州市晋江市青阳街道陈村社区金融广场 2 号楼 6 层公共办公 区 B-050 通讯地址：福建省泉州市丰泽区大兴街 1466 号东海泰禾广场 12 幢 2425 室 信息披露义务人 2 名称：福建汇水至成股权投资合伙企业（有限合伙） 注册地址：福建省泉州市晋江市青阳街道陈村社区金融广场 2 号楼 6 层公共办公 区 B-047 通讯地址：福建省泉州市丰泽区大兴街 1466 号东海泰禾广场 12 幢 2425 室 信息披露义务人 3 名称：福建汇火至成股权投资合伙企业（有限合伙） 注册地址：福建省泉州市晋江市青阳街道陈村社区金融广场 2 号楼 6 层公共办公 区 B-048 通讯地址：福建省泉州市丰泽区大兴街 1466 号东海泰禾广场 12 幢 2425 室 股份变动性质：股份减少 签署日期：2023 年 9 月 8 日 1 信息披露义务人声明 ...

证券代码：300955 证券简称：嘉亨家化 公告编号：2023-034 嘉亨家化股份有限公司 关于为全资子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 嘉亨家化股份有限公司（以下简称"公司"或"嘉亨家化"）于 2023 年 4 月 21 日分别召开第二届董事会第九次会议和第二届监事会第八次会议、于 2023 年 5 月 15 日召开 2022 年年度股东大会，审议通过了《关于 2023 年度公司及全资子 公司申请综合授信、提供担保额度预计的议案》，同意 2023 年度公司及全资子 公司预计向银行等金融机构申请不超过人民币 9.7 亿元（包括新增及原授信到期 后续期）的综合授信额度，其中公司对全资子公司授信预计提供合计不超过人民 币 8.5 亿元的担保额度，授信额度有效期为自公司 2022 年年度股东大会审议通 过之日起至 2024 年度授信及担保方案经公司股东大会审议批准之日止，授信期 限内，授信额度可循环使用。具体内容详见公司于 2023 年 4 月 24 日在巨潮资讯 网（www.cninfo.com.cn）披露 ...